TK/Flt3L gene therapy capitalizes on this immune- permissive state by not only directly inducing tumor cell death but also by amplifying innate and adaptive anti-tumor immune responses through dendritic cell activation and cytotoxic T cell expansion37. This evidence concerns the gene FLT3LG and neoplasm.